QVT Financial LP - Q2 2017 holdings

$3.75 Billion is the total value of QVT Financial LP's 74 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 45.5% .

 Value Shares↓ Weighting
AXGT  AXOVANT SCIENCES LTD$1,739,250,000
+55.2%
75,000,0000.0%46.44%
+33.4%
MYOV  MYOVANT SCIENCES LTD$435,606,000
-0.3%
37,231,3420.0%11.63%
-14.3%
XBI SellSPDR SERIES TRUSTput$308,720,000
-23.6%
4,000,000
-31.4%
8.24%
-34.3%
 TAL ED GROUPnote 2.500% 5/1$135,547,000
+15.2%
29,000,0000.0%3.62%
-1.0%
NewMICRON TECHNOLOGY INCnote 2.125% 2/1$91,393,00033,172,000
+100.0%
2.44%
 VERISIGN INCsdcv 3.250% 8/1$78,416,000
+7.2%
28,600,0000.0%2.09%
-7.8%
MMYT BuyMAKEMYTRIP LIMITED MAURITIUS$73,549,000
+6.7%
2,264,837
+10.3%
1.96%
-8.3%
SellINTEL CORPsdcv 12/1$69,501,000
-15.9%
53,047,000
-12.0%
1.86%
-27.7%
ABUS  ARBUTUS BIOPHARMA CORP$57,649,000
+10.8%
16,013,5400.0%1.54%
-4.8%
IBB SellISHARES TRnasdq biotec etf$52,973,000
-22.2%
170,837
-26.4%
1.41%
-33.1%
AGNPRA  ALLERGAN PLCpfd conv ser a$43,285,000
+2.1%
50,0000.0%1.16%
-12.2%
NewMICROCHIP TECHNOLOGY INCnote 1.625% 2/1$43,271,00028,729,000
+100.0%
1.16%
 SHIP FINANCE INTERNATIONAL Lnote 3.250% 2/0$42,869,000
-1.4%
39,986,0000.0%1.14%
-15.2%
BuyANTHEM INCnote 2.750%10/1$42,702,000
+12.6%
16,517,000
+0.1%
1.14%
-3.1%
NYT SellNEW YORK TIMES COcl a$26,010,000
-2.2%
1,469,488
-20.4%
0.69%
-16.0%
NTES NewNETEASE INCsponsored adr$25,190,00083,790
+100.0%
0.67%
KMX SellCARMAX INC$23,358,000
-3.8%
370,402
-9.7%
0.62%
-17.2%
SellHERBALIFE LTDnote 2.000% 8/1$23,095,000
-3.9%
22,000,000
-12.0%
0.62%
-17.3%
KANG BuyIKANG HEALTHCARE GROUP INCsponsored adr$20,440,000
-10.3%
1,665,866
+6.7%
0.55%
-22.9%
ADS SellALLIANCE DATA SYSTEMS CORP$20,069,000
-4.9%
78,185
-7.8%
0.54%
-18.2%
RICE BuyRICE ENERGY INC$19,502,000
+73.9%
732,317
+54.7%
0.52%
+49.7%
BuyNOVELLUS SYS INCnote 2.625% 5/1$18,340,000
+207.0%
4,370,000
+178.3%
0.49%
+163.4%
GS  GOLDMAN SACHS GROUP INC$18,182,000
-3.4%
81,9400.0%0.48%
-17.1%
AVXS  AVEXIS INC$18,104,000
+8.1%
220,3560.0%0.48%
-7.1%
AGEN BuyAGENUS INC$17,588,000
+13.8%
4,498,146
+9.8%
0.47%
-2.1%
ATEX SellPDVWIRELESS INC$17,065,000
+0.8%
839,236
-6.1%
0.46%
-13.3%
NRE SellNORTHSTAR REALTY EUROPE CORP$16,888,000
-10.0%
1,356,743
-18.5%
0.45%
-22.6%
TWX  TIME WARNER INC$16,218,000
+2.8%
161,5180.0%0.43%
-11.6%
XLRN  ACCELERON PHARMA INC$14,600,000
+14.8%
480,4370.0%0.39%
-1.3%
EURN BuyEURONAV NV ANTWERPEN$13,848,000
+29.8%
1,752,883
+29.8%
0.37%
+11.8%
AMBA SellAMBARELLA INC$12,078,000
-23.2%
248,777
-13.5%
0.32%
-34.2%
HD  HOME DEPOT INC$11,812,000
+4.5%
77,0000.0%0.32%
-10.3%
IBKR NewINTERACTIVE BROKERS GROUP IN$11,226,000300,000
+100.0%
0.30%
NewAMAG PHARMACEUTICALS INCnote 3.250% 6/0$10,639,00011,000,000
+100.0%
0.28%
NAT BuyNORDIC AMERICAN TANKERS LIMIput$10,398,000
+57.7%
1,640,100
+103.4%
0.28%
+35.6%
NewBROCADE COMMUNICATIONS SYS Inote 1.375% 1/0$10,148,00010,000,000
+100.0%
0.27%
JPM  JPMORGAN CHASE & CO$10,053,000
+4.1%
109,9850.0%0.27%
-10.7%
HUNTF NewHUNTER MARITIME ACQUISITIONcl a$9,890,0001,000,000
+100.0%
0.26%
SellDHT HOLDINGS INCdebt 4.500%10/0$9,209,000
-17.7%
9,440,000
-17.5%
0.25%
-29.3%
CALM SellCAL MAINE FOODS INC$8,740,000
-6.9%
220,700
-13.5%
0.23%
-20.2%
COG SellCABOT OIL & GAS CORP$8,145,000
-37.4%
324,742
-40.3%
0.22%
-46.3%
WFC  WELLS FARGO CO NEW$7,852,000
-0.5%
141,7120.0%0.21%
-14.3%
ASMB SellASSEMBLY BIOSCIENCES INC$7,666,000
-51.0%
392,487
-43.5%
0.20%
-57.8%
GTN SellGRAY TELEVISION INC$7,423,000
-30.6%
541,789
-26.5%
0.20%
-40.4%
AR SellANTERO RES CORP$6,989,000
-18.0%
323,413
-13.4%
0.19%
-29.4%
XNCR  XENCOR INC$6,361,000
-11.8%
301,3250.0%0.17%
-24.1%
PYPL SellPAYPAL HLDGS INC$5,724,000
-66.9%
106,660
-73.5%
0.15%
-71.6%
ADAP  ADAPTIMMUNE THERAPEUTICS PLCsponds adr$5,655,000
-18.5%
1,360,6470.0%0.15%
-30.1%
SBGI SellSINCLAIR BROADCAST GROUP INCcl a$5,309,000
-67.0%
161,358
-59.4%
0.14%
-71.5%
NXST NewNEXSTAR MEDIA GROUP INCcl a$5,260,00087,959
+100.0%
0.14%
IOVA NewIOVANCE BIOTHERAPEUTICS INC$4,690,000660,809
+100.0%
0.12%
TNK SellTEEKAY TANKERS LTDcl a$4,138,000
-37.8%
2,200,903
-32.1%
0.11%
-46.6%
ARGX NewARGENX SEsponsored adr$3,881,000200,000
+100.0%
0.10%
SRPT SellSAREPTA THERAPEUTICS INC$3,735,000
-43.1%
110,812
-50.0%
0.10%
-51.0%
XRT SellSPDR SERIES TRUSTs&p retail etf$3,577,000
-44.5%
87,795
-42.5%
0.10%
-52.0%
ACAD SellACADIA PHARMACEUTICALS INC$3,393,000
-47.2%
121,653
-35.0%
0.09%
-54.5%
KRE  SPDR SERIES TRUSTs&p regl bkg$3,379,000
+0.6%
61,4910.0%0.09%
-13.5%
BLUE SellBLUEBIRD BIO INC$3,019,000
-58.0%
28,739
-63.6%
0.08%
-63.7%
ICPT SellINTERCEPT PHARMACEUTICALS IN$3,049,000
-51.3%
25,184
-54.5%
0.08%
-58.5%
TSRO SellTESARO INC$2,962,000
-46.8%
21,176
-41.5%
0.08%
-54.3%
RLGY NewREALOGY HLDGS CORP$2,920,00090,000
+100.0%
0.08%
MU NewMICRON TECHNOLOGY INC$2,377,00079,600
+100.0%
0.06%
BMRN SellBIOMARIN PHARMACEUTICAL INC$2,161,000
-57.9%
23,799
-59.3%
0.06%
-63.8%
NAT NewNORDIC AMERICAN TANKERS LIMI$1,395,000220,000
+100.0%
0.04%
PTN  PALATIN TECHNOLOGIES INC$1,293,000
+31.3%
4,296,8470.0%0.04%
+12.9%
XBI NewSPDR SERIES TRUSTs&p biotech$1,288,00016,693
+100.0%
0.03%
TCON  TRACON PHARMACEUTICALS INC$815,000
-36.0%
339,5390.0%0.02%
-45.0%
 VECTOR GROUP LTDfrnt 1/1$736,000
+0.8%
500,0000.0%0.02%
-13.0%
HYG SellISHARES TRiboxx hi yd etf$639,000
-59.6%
7,235
-59.8%
0.02%
-65.3%
CLLS NewCELLECTIS S Asponsored ads$655,00025,353
+100.0%
0.02%
AKTX SellAKARI THERAPEUTICS PLCsponsored adr$531,000
-71.9%
132,077
-36.8%
0.01%
-76.3%
INSW  INTERNATIONAL SEAWAYS INC$397,000
+13.4%
18,3090.0%0.01%0.0%
BIVV  BIOVERATIV INC$354,000
+10.6%
5,8790.0%0.01%
-10.0%
HNTWF NewHUNTER MARITIME ACQUISITION*w exp 99/99/999$16,000500,000
+100.0%
0.00%
GLFMQ ExitGULFMARK OFFSHORE INCcl a new$0-607,500
-100.0%
-0.01%
PFF ExitISHARES TRu.s. pfd stk etf$0-51,194
-100.0%
-0.06%
BIIB ExitBIOGEN INC$0-11,760
-100.0%
-0.10%
CASC ExitCASCADIAN THERAPEUTICS INC$0-800,000
-100.0%
-0.10%
BLCM ExitBELLICUM PHARMACEUTICALS INC$0-300,723
-100.0%
-0.12%
RGNX ExitREGENXBIO INC$0-193,432
-100.0%
-0.12%
ARWR ExitARROWHEAD PHARMACEUTICALS IN$0-2,556,256
-100.0%
-0.15%
DHT ExitDHT HOLDINGS INC$0-1,206,051
-100.0%
-0.17%
ExitPRICELINE GRP INCnote 1.000% 3/1$0-2,880,000
-100.0%
-0.17%
EPZM ExitEPIZYME INC$0-355,445
-100.0%
-0.19%
BGNE ExitBEIGENE LTDsponsored adr$0-170,000
-100.0%
-0.19%
LBIO ExitLION BIOTECHNOLOGIES INC$0-1,385,309
-100.0%
-0.31%
HNTUF ExitHUNTER MARITIME ACQUISITIONunit 99/99/9999$0-1,000,000
-100.0%
-0.32%
ExitNXP SEMICONDUCTORS N Vdbcv 1.000%12/0$0-10,000,000
-100.0%
-0.36%
ExitCTRIP COM INTL LTDnote 1.000% 7/0$0-12,650,000
-100.0%
-0.44%
EQC ExitEQUITY COMWLTH$0-554,688
-100.0%
-0.54%
ExitMICROCHIP TECHNOLOGY INCsdcv 2.125%12/1$0-6,752,000
-100.0%
-0.65%
INTC ExitINTEL CORP$0-587,314
-100.0%
-0.66%
ExitCTRIP COM INTL LTDnote 1.250%10/1$0-24,500,000
-100.0%
-1.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MAKEMYTRIP LIMITED MAURITIUS38Q3 20236.2%
NEW YORK TIMES CO34Q3 20232.6%
ACCELERON PHARMA INC32Q3 20212.8%
JPMORGAN CHASE & CO32Q3 20212.2%
SAREPTA THERAPEUTICS INC32Q3 20231.1%
BIOMARIN PHARMACEUTICAL INC32Q3 20230.5%
GOLDMAN SACHS GROUP INC30Q3 20235.4%
ACADIA PHARMACEUTICALS INC28Q3 20230.2%
WELLS FARGO CO NEW27Q4 20201.5%
NEXSTAR MEDIA GROUP INC26Q3 20233.4%

View QVT Financial LP's complete holdings history.

Latest significant ownerships (13-D/G)
QVT Financial LP Q2 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
MP Materials Corp. / DEMay 18, 20238,853,7125.0%
Grindrod Shipping Holdings Ltd.Sold outFebruary 14, 202200.0%
AEHR TEST SYSTEMSSold outFebruary 14, 202000.0%
Arbutus Biopharma CorpSold outJuly 12, 201900.0%
Axovant Gene Therapies Ltd.Sold outJuly 12, 201900.0%
Myovant Sciences Ltd.Sold outJuly 12, 201900.0%
Urovant Sciences Ltd.Sold outJuly 12, 201900.0%
Axovant Sciences Ltd.March 19, 2019105,952,38158.2%
Hunter Maritime Acquisition Corp.Sold outFebruary 14, 201900.0%
AGENUS INCFebruary 14, 20183,201,2633.2%

View QVT Financial LP's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-07
SC 13G/A2024-03-07
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
42023-10-02
1442023-09-28
13F-HR2023-08-14
SC 13D/A2023-05-18
13F-HR2023-05-15

View QVT Financial LP's complete filings history.

Compare quarters

Export QVT Financial LP's holdings